BlackRock Investment Management’s Gilead Sciences GILD Stock Holding History

BlackRock Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$400M	Sell	5,591,136 -55,717	-1%	-$4.14M	0.46%	37
2016 Q3	$447M	Buy	5,646,853 +806,723	+17%	+$65.5M	0.55%	30
2016 Q2	$404M	Buy	4,840,130 +881,262	+22%	+$78.2M	0.51%	33
2016 Q1	$364M	Buy	3,958,868 +149,368	+4%	+$13.5M	0.47%	38
2015 Q4	$385M	Buy	3,809,500 +505,626	+15%	+$52.6M	0.49%	33
2015 Q3	$324M	Buy	3,303,874 +114,701	+4%	+$12.7M	0.44%	45
2015 Q2	$373M	Buy	3,189,173 +216,981	+7%	+$23.7M	0.46%	40
2015 Q1	$292M	Sell	2,972,192 -597,752	-17%	-$60.7M	0.38%	53
2014 Q4	$337M	Buy	3,569,944 +49,976	+1%	+$5.17M	0.45%	41
2014 Q3	$375M	Sell	3,519,968 -973,868	-22%	-$95.4M	0.52%	33
2014 Q2	$373M	Sell	4,493,836 -457,013	-9%	-$35.6M	0.5%	35
2014 Q1	$351M	Buy	4,950,849 +530,100	+12%	+$41.6M	0.51%	35
2013 Q4	$332M	Buy	4,420,749 +352,535	+9%	+$24.5M	0.49%	35
2013 Q3	$256M	Buy	4,068,214 +440,066	+12%	+$26.3M	0.42%	44
2013 Q2	$186M	Buy	+3,628,148	New	+$189M	0.33%	64

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's GILD Position: Q4 2016 in Review

BlackRock Investment Management reduced its Gilead Sciences (GILD) stake by 0.99% in Q4 2016, selling an estimated $4.14M and leaving 5,591,136 shares worth $400M. The position accounts for 0.46% of the portfolio, ranked #37.

BlackRock Investment Management first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $447M in Q3 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

BlackRock Investment Management held 5,591,136 shares of Gilead Sciences worth $400M as of Q4 2016.
BlackRock Investment Management sold 55,717 Gilead Sciences shares in Q4 2016, an estimated $4.14M.
Gilead Sciences made up 0.46% of BlackRock Investment Management's portfolio in Q4 2016, its #37 holding.
BlackRock Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Gilead Sciences position peaked at $447M in Q3 2016.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.